BellBrook Labs

Founded in 2006, BellBrook Labs develops innovative high-throughput screening (HTS) assay technologies and biochemical assay solutions that help accelerate enzyme-targeted drug discovery. Specialising in research areas such as kinases, ATPases, GTPases, methyltransferases, DNA damage repair, innate immunity, and cell signalling, BellBrook offers a portfolio of assay kits, recombinant enzymes, screening reagents, and custom assay development services. Through its proprietary Transcreener®, AptaFluor®, and Enzolution™ platforms, BellBrook Labs is committed to advancing the discovery of new therapeutics by providing robust, reliable, and easy-to-implement solutions for pharmaceutical, biotechnology, and academic researchers worldwide.

Cambridge Bioscience is pleased to provide BellBrook Labs products in the UK and Ireland.

BellBrook Labs, HTS assays, high throughput screening assays, drug discovery assays, kinase assays, enzyme assays, ATPase assays, GTPase assays, methyltransferase assays, Transcreener, AptaFluor, recombinant enzymes, inhibitor screening, biochemical assays, drug discovery reagents,

In this section

Contact our BellBrook Labs specialists